Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
46.50    -1.00 (-2.11%)
Bid:
45.00
Ask:
48.00
Spread: 3.00 (6.667%)
Market Cap: £27.58m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Trading Update

29 Jan 2026 07:00

RNS Number : 8134Q
KRM22 PLC
29 January 2026
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company, with a particular focus on risk management in capital markets, today issues the following trading update for the 12-month period ended 31 December 2025 ("FY2025").

 

The Company expects to report audited results for FY2025 in May 2026, and is pleased to report the following financial highlights*:

 

· ARR at 31 December 2025 of £7.6m (FY2024: £6.6m, £6.4m at constant FX rates) - growth of 19% at constant FX rates

New contracted ARR in the year of £1.6m (FY2024: £1.7m)

· Total revenue recognised of approximately £7.5m (FY2024: £6.8m) - growth of 11%

· Adjusted EBITDA: £0.7m (FY2024: £1.0m)

· Gross cash as of 31 December 2025 of £5.2m with net cash of £5.2m (FY2024: gross cash of £1.0m, net debt of £3.5m)

· Successful £9.2m fundraise completed in November 2025

 

As reported in the trading update on 7th August 2025, approximately 50% of Group ARR is derived from USD denominated contracts and, with a 7 per cent change in GBP:USD FX rates in FY2025, ARR at the start of FY2025 restated using a constant FX rate as at the end of FY2025 was £6.4m (£6.6m as previously reported using 31 December 2024 FX rates). 

 

Using constant exchange rates, the change in ARR during FY2025 was a net increase of £1.2m. This was driven by £1.6m from cross-sales to existing customers and contractual price increases. Specifically, cross-sales of the Risk Manager, Limits Manager, and Market Surveillance applications generated £1.1m, while contractual price increases across the same applications added another £0.5m. This growth was partially offset by a churn of £0.4m, which was mainly attributed to two institutional customers who cancelled their license of the Market Surveillance application whilst, in both cases, singing new multi-year contracts to license other KRM22 applications.

 

With the successful fundraise completed in November 2025 raising £9.2m, KRM22 is now debt free and, following receipt of a three-year license fee payment from one its customers, the Company had a strong cash position at 31 December 2025 of £5.2m. This cash will be utilised to support the growth strategy presented to investors, namely investment in additional sales, marketing and development resource to allow KRM22 to expand its existing suite of risk management applications to offer multi-asset solutions to the capital markets industry. Importantly, post the fund raising, management is able to focus on growing the business and delivering on the Company's strategy, without the distraction of managing a complex balance sheet and operating within restrictive financial covenants.

 

Dan Carter, CEO commented: "KRM22 delivered a solid performance in 2025, with ARR growing 19% to £7.6m with new contracted ARR of £1.6m reflecting the continued demand for our applications. With our year‑end cash position strengthened significantly to £5.2m, we enter 2026 with a strong sales pipeline, a robust balance sheet, and clear strategic priorities, positioning the business for continued growth."

 

\* The financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For further information please contact:

 

KRM22 plc

Dan Carter, CEO

Kim Suter, CFO

 

InvestorRelations@krm22.com

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Stephen Keys / Isaac Hooper (Corporate Finance)

Sunila de Silva (ECM)

 

+44 (0)20 7220 0500

 

 

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEWEFAEMSESF
Date   Source Headline
18th Sep 20209:26 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSNew Debt Facility
16th Sep 20207:00 amRNSInterim Results
17th Aug 20207:00 amRNSNew Customer Contract
23rd Jul 202010:49 amRNSIssue of Options
21st Jul 20207:00 amRNSTrading Update
3rd Jul 20201:37 pmRNSHolding(s) in Company
29th Jun 20207:00 amRNSConversion of Convertible Loan Note
25th Jun 202011:51 amRNSResult of AGM
2nd Jun 20207:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20207:00 amRNSSubscription
21st May 20207:00 amRNSAUDITED RESULTS FOR THE YEAR ENDED 31 DEC 2019
20th May 20204:41 pmRNSHolding(s) in Company
19th May 20207:00 amRNSHolding(s) in Company
18th May 20208:53 amRNSHolding(s) in Company
14th May 20207:00 amRNSCompletion of Equity Fundraising
11th May 20207:00 amRNSUpdate on Equity Fundraising
7th May 20202:47 pmRNSStatement re. share price movement
17th Apr 20207:00 amRNSConsolidation of ownership of Irisium Ltd
2nd Apr 20207:00 amRNSDirectorate Changes
2nd Apr 20207:00 amRNSTrading Update
13th Jan 20204:30 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSTrading Update
3rd Dec 20197:00 amRNSDirectorate Changes
20th Nov 20198:03 amRNSKRM22 announces Market Risk solution for the GRP
14th Nov 20195:23 pmRNSHolding(s) in Company
7th Nov 20197:01 amRNSKRM22 announces partnership with deltaconX
7th Nov 20197:00 amRNSPlacing
31st Oct 20197:00 amRNSBusiness Update
3rd Oct 20197:00 amRNSNew customer contract
24th Sep 20194:40 pmRNSSecond Price Monitoring Extn
24th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
11th Sep 20197:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20197:00 amRNSKRM22 adds Digital Client Onboarding to offering
11th Jul 20197:00 amRNSPartnership with Quant Foundry
11th Jul 20197:00 amRNSHalf Year Trading Update
28th Jun 201911:52 amRNSResult of AGM
25th Jun 201910:17 amRNSHolding(s) in Company
19th Jun 20197:00 amRNSPartnership with Neotas
6th Jun 20199:00 amRNSNotice of AGM & Posting of Annual Report
6th Jun 20197:00 amRNSSubscription
5th Jun 20196:13 pmRNSHolding(s) in Company
3rd Jun 20197:01 amRNSDirector role change
3rd Jun 20197:00 amRNSFinal Results
3rd Jun 20197:00 amRNSCompletion of Acquisition
31st May 20197:00 amRNSKRM22 announces partnership with Trailight Ltd
30th May 20197:00 amRNSAcquisition of Object+
1st May 20197:00 amRNSUpdate on Fundraising
30th Apr 20197:00 amRNSDirectorate Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.